[1]
Sarker, U.K. et al. 2023. Randomized two way crossover open label study to compare the bioequivalence of LOSARDIL 100 TM (Drug International Ltd, Bangladesh) and COZAAR TM (Merck Sharp & Dhome Ltd, UK) in Bangladeshi normal male volunteers. Asian Journal of Pharmaceutical Research and Development. 11, 1 (Feb. 2023), 8–13. DOI:https://doi.org/10.22270/ajprd.v11i1.1228.